Hancom Lifecare Inc. (KRX:372910)
South Korea · Delayed Price · Currency is KRW 1,679.00
-6.00 (-0.36%)
At close: Jul 28, 2026
Hancom Lifecare Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 46,465 | 83,438 | 86,898 | 125,503 | 161,895 | 245,472 | |
Market Cap Growth | -42.20% | -3.98% | -30.76% | -22.48% | -34.05% | - |
Enterprise Value | 11,602 | 48,023 | 67,570 | 108,361 | 114,370 | 197,998 |
Last Close Price | 1679.00 | 3015.00 | 3140.00 | 4535.00 | 5850.00 | 8870.00 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 11.78 | 152.18 | 17.59 | 50.77 |
Forward PE | 12.06 | 11.39 | 10.40 | - | - | - |
PS Ratio | 0.51 | 0.91 | 0.83 | 1.11 | 1.62 | 2.03 |
PB Ratio | 0.37 | 0.65 | 0.64 | 0.98 | 1.26 | 2.10 |
P/TBV Ratio | 0.38 | 0.67 | 0.66 | 1.01 | 1.32 | 2.22 |
P/FCF Ratio | 3.67 | 4.92 | 4.78 | - | - | 13.04 |
P/OCF Ratio | 2.61 | 3.68 | 3.90 | - | 31.85 | 8.75 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.13 | 0.52 | 0.65 | 0.96 | 1.14 | 1.63 |
EV/EBITDA Ratio | - | - | 5.19 | 12.15 | 19.72 | 15.70 |
EV/EBIT Ratio | - | - | 9.11 | 59.15 | - | 41.42 |
EV/FCF Ratio | 0.92 | 2.83 | 3.72 | - | - | 10.52 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.03 | 0.05 |
Debt / EBITDA Ratio | - | - | 0.04 | 0.09 | 0.75 | 0.44 |
Debt / FCF Ratio | 0.03 | 0.03 | 0.03 | - | - | 0.30 |
Net Debt / Equity Ratio | -0.28 | -0.40 | -0.25 | -0.12 | -0.43 | -0.49 |
Net Debt / EBITDA Ratio | 15.32 | 28.35 | -2.60 | -1.77 | -9.50 | -4.52 |
Net Debt / FCF Ratio | -2.81 | -3.00 | -1.86 | 1.17 | 80.80 | -3.03 |
Asset Turnover | 0.46 | 0.46 | 0.55 | 0.58 | 0.47 | 0.64 |
Inventory Turnover | 1.39 | 1.93 | 1.73 | 2.09 | 2.19 | 2.38 |
Quick Ratio | 0.51 | 0.76 | 0.59 | 0.40 | 0.83 | 0.70 |
Current Ratio | 1.61 | 1.65 | 1.97 | 1.95 | 1.49 | 1.20 |
Return on Equity (ROE) | -5.49% | -5.83% | 5.56% | 0.68% | 7.58% | 6.25% |
Return on Assets (ROA) | -2.19% | -2.04% | 2.44% | 0.59% | -0.42% | 1.57% |
Return on Invested Capital (ROIC) | -8.35% | -7.38% | 5.60% | 1.06% | -1.50% | 6.90% |
Return on Capital Employed (ROCE) | -5.50% | -5.10% | 5.40% | 1.40% | -1.10% | 3.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -15.42% | -9.26% | 8.49% | 0.66% | 5.68% | 1.97% |
FCF Yield | 27.23% | 20.33% | 20.90% | -10.80% | -0.42% | 7.67% |
Buyback Yield / Dilution | - | - | - | - | -12.31% | 1.17% |